Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer

NCT01116791 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

34

Enrollment

OTHER

Sponsor class

Stopped Insufficient enrollment in Pancreatic \& Biliary arm

Conditions

Peritoneal Carcinomatosis
Gastrointestinal Cancer

Interventions

PROCEDURE: Cytoreductive Surgery (CRS) plus Hyperthermic Intraoperative Peritoneal Chemotherapy with Cisplatin (HIPC)

Sponsor

Baki Topal

Collaborators

[object Object]